Akira Haketa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Akira Haketa has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Hiroki Kobayashi
Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan
3 shared publicationsHiromasa Otsuka
Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan
3 shared publicationsMasanori Abe
Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan
3 shared publicationsMasayoshi Soma
Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan
3 shared publicationsNoboru Fukuda
Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan
3 shared publicationsSho Tanaka
Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan
3 shared publications
Latest Publications
- 19 December 2016
- Published by Wiley in Clinical Endocrinology
- Vol. 86 (4) , 467-472
Scoring system for the diagnosis of bilateral primary aldosteronism in the outpatient setting before adrenal venous sampling
Summary: Objective: The only reliable method for subtyping primary aldosteronism (PA) is adrenal venous sampling (AVS), which is costly and time‐consuming. Considering the limited availability of AVS, it would be helpful to obtain information on the diagnosis of bilateral hyperaldosteronism (BHA) from routine tests. We aimed to establish new, simple criteria for outpatients to diagnose BHA from PA before AVS.Design: We retrospectively analysed 82 patients who were diagnosed with PA and underwent AVS. Thirty‐seven patients were diagnosed with unilateral hyperaldosteronism (UHA), and 36 with BHA and nine were undetermined. Among the variables that were significantly different between UHA and BHA in the univariate analysis, we chose three variables to be included in multivariate logistic regression models and constructed a subtype prediction score.Results: The subtype prediction score was calculated as follows: 3 points for no adrenal nodules on computed tomography imaging, 2 for serum potassium of ≥3·5 mmol/l and 2 for aldosterone‐to‐renin ratio of <490 after a captopril challenge test. Receiver operating characteristic curve analysis for the ability to discriminate BHA from UHA showed that a score of 7 points had 50% sensitivity and 100% specificity and a score of 5 points had 67% sensitivity and 94% specificity (area under the curve: 0·922; 95% CI: 0·863–0·980).Conclusions: Our new, simple criteria specifically distinguished BHA from UHA in the outpatient setting before AVS. Furthermore, not only endocrinologists but also general internists can use this convenient, safe scoring system.
- 19 December 2016
- Published by Wiley in Clinical Endocrinology
- Vol. 86 (4) , 467-472
Scoring system for the diagnosis of bilateral primary aldosteronism in the outpatient setting before adrenal venous sampling
Summary: Objective: The only reliable method for subtyping primary aldosteronism (PA) is adrenal venous sampling (AVS), which is costly and time‐consuming. Considering the limited availability of AVS, it would be helpful to obtain information on the diagnosis of bilateral hyperaldosteronism (BHA) from routine tests. We aimed to establish new, simple criteria for outpatients to diagnose BHA from PA before AVS.Design: We retrospectively analysed 82 patients who were diagnosed with PA and underwent AVS. Thirty‐seven patients were diagnosed with unilateral hyperaldosteronism (UHA), and 36 with BHA and nine were undetermined. Among the variables that were significantly different between UHA and BHA in the univariate analysis, we chose three variables to be included in multivariate logistic regression models and constructed a subtype prediction score.Results: The subtype prediction score was calculated as follows: 3 points for no adrenal nodules on computed tomography imaging, 2 for serum potassium of ≥3·5 mmol/l and 2 for aldosterone‐to‐renin ratio of <490 after a captopril challenge test. Receiver operating characteristic curve analysis for the ability to discriminate BHA from UHA showed that a score of 7 points had 50% sensitivity and 100% specificity and a score of 5 points had 67% sensitivity and 94% specificity (area under the curve: 0·922; 95% CI: 0·863–0·980).Conclusions: Our new, simple criteria specifically distinguished BHA from UHA in the outpatient setting before AVS. Furthermore, not only endocrinologists but also general internists can use this convenient, safe scoring system.
- 5 December 2016
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 19 (3) , 280-286
Plasma adrenocorticotropic hormone but not aldosterone is correlated with blood pressure in patients with aldosterone‐producing adenomas
Although plasma aldosterone concentration (PAC) varies depending on primary aldosteronism (PA) subtypes, patients with different subtypes may have similar blood pressure (BP). The authors hypothesized that hormones other than aldosterone might influence BP in PA patients. A total of 73 PA cases, including 30 cases of aldosterone‐producing adenomas (APAs), 29 cases of bilateral hyperaldosteronism, and 24 control cases of essential hypertension were enrolled retrospectively. The authors examined the levels of aldosterone, cortisol, renin, and adrenocorticotropic hormone (ACTH) measured at 12 am, 6 am, 12 pm, and 6 pm and BP in the early morning (6 am to 7 am), late morning (9 am to 11 am), and early evening (5 pm to 7 pm). Results showed no statistically significant correlation between PAC and BP in the patients with PA; however, early and late morning systolic BP strongly correlated with ACTH at 6 am in patients with APA. These results suggest that hormones other than aldosterone, such as ACTH, may affect BP in patients with APA.
- 5 December 2016
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 19 (3) , 280-286
Plasma adrenocorticotropic hormone but not aldosterone is correlated with blood pressure in patients with aldosterone‐producing adenomas
Although plasma aldosterone concentration (PAC) varies depending on primary aldosteronism (PA) subtypes, patients with different subtypes may have similar blood pressure (BP). The authors hypothesized that hormones other than aldosterone might influence BP in PA patients. A total of 73 PA cases, including 30 cases of aldosterone‐producing adenomas (APAs), 29 cases of bilateral hyperaldosteronism, and 24 control cases of essential hypertension were enrolled retrospectively. The authors examined the levels of aldosterone, cortisol, renin, and adrenocorticotropic hormone (ACTH) measured at 12 am, 6 am, 12 pm, and 6 pm and BP in the early morning (6 am to 7 am), late morning (9 am to 11 am), and early evening (5 pm to 7 pm). Results showed no statistically significant correlation between PAC and BP in the patients with PA; however, early and late morning systolic BP strongly correlated with ACTH at 6 am in patients with APA. These results suggest that hormones other than aldosterone, such as ACTH, may affect BP in patients with APA.
- 13 December 2015
- Published by Wiley in Clinical Endocrinology
- Vol. 84 (6) , 814-821
Subtype prediction in primary aldosteronism: measurement of circadian variation of adrenocortical hormones and 24‐h urinary aldosterone
Summary: Objective: Currently, adrenal venous sampling (AVS) is the only reliable method to distinguish unilateral from bilateral hyperaldosteronism in primary aldosteronism (PA). However, AVS is costly and time‐consuming compared with simple blood tests. In this study, we conducted a retrospective study to determine whether circadian variation in plasma adrenocortical hormone levels (i.e. aldosterone, cortisol and ACTH) and a 24‐h urinary aldosterone could contribute to the clinical differentiation between unilateral hyperaldosteronism (UHA) and bilateral hyperaldosteronism (BHA).Design: In 64 patients who were diagnosed with PA and underwent AVS, 32 and 22 patients were diagnosed with UHA and BHA, respectively. Plasma adrenocortical hormone levels at 0:00, 6:00, 12:00 and 18:00 and 24‐h urinary aldosterone under a condition of 6 g daily dietary sodium chloride intake were measured.Results: Baseline plasma aldosterone concentration (PAC) and 24‐h urinary aldosterone level in patients with UHA were significantly higher than in patients with BHA, particularly at 6:00. The area under the ROC curve for PAC at 0:00, 6:00, 12:00 and 18:00 and 24‐h urinary aldosterone to discriminate UHA and BHA was 0·839 [95% confidence interval (CI); 0·73−0·95], 0·922 (95% CI; 0·85−1·00), 0·875 (95% CI; 0·78−0·97), 0·811 (95% CI; 0·69−0·93), 0·898 (95% CI; 0·81−0·99), respectively.Conclusions: PAC at different blood sampling times and 24‐h urinary aldosterone level may be diagnostically helpful in discriminating between UHA and BHA. We believe that these tests could reduce the number of unnecessary AVS procedures.
- 13 December 2015
- Published by Wiley in Clinical Endocrinology
- Vol. 84 (6) , 814-821
Subtype prediction in primary aldosteronism: measurement of circadian variation of adrenocortical hormones and 24‐h urinary aldosterone
Summary: Objective: Currently, adrenal venous sampling (AVS) is the only reliable method to distinguish unilateral from bilateral hyperaldosteronism in primary aldosteronism (PA). However, AVS is costly and time‐consuming compared with simple blood tests. In this study, we conducted a retrospective study to determine whether circadian variation in plasma adrenocortical hormone levels (i.e. aldosterone, cortisol and ACTH) and a 24‐h urinary aldosterone could contribute to the clinical differentiation between unilateral hyperaldosteronism (UHA) and bilateral hyperaldosteronism (BHA).Design: In 64 patients who were diagnosed with PA and underwent AVS, 32 and 22 patients were diagnosed with UHA and BHA, respectively. Plasma adrenocortical hormone levels at 0:00, 6:00, 12:00 and 18:00 and 24‐h urinary aldosterone under a condition of 6 g daily dietary sodium chloride intake were measured.Results: Baseline plasma aldosterone concentration (PAC) and 24‐h urinary aldosterone level in patients with UHA were significantly higher than in patients with BHA, particularly at 6:00. The area under the ROC curve for PAC at 0:00, 6:00, 12:00 and 18:00 and 24‐h urinary aldosterone to discriminate UHA and BHA was 0·839 [95% confidence interval (CI); 0·73−0·95], 0·922 (95% CI; 0·85−1·00), 0·875 (95% CI; 0·78−0·97), 0·811 (95% CI; 0·69−0·93), 0·898 (95% CI; 0·81−0·99), respectively.Conclusions: PAC at different blood sampling times and 24‐h urinary aldosterone level may be diagnostically helpful in discriminating between UHA and BHA. We believe that these tests could reduce the number of unnecessary AVS procedures.